Cite
HARVARD Citation
Morabito, F. et al. (2020). TP53 dysfunction in chronic lymphocytic leukemia: clinical relevance in the era of B-cell receptors and BCL-2 inhibitors. Expert opinion on investigational drugs. pp. 869-880. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Morabito, F. et al. (2020). TP53 dysfunction in chronic lymphocytic leukemia: clinical relevance in the era of B-cell receptors and BCL-2 inhibitors. Expert opinion on investigational drugs. pp. 869-880. [Online].